News

Regeneron Pharmaceuticals’ new treatment for visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO) has been approved by the European Commission.

A prospective study randomly assigned 64 patients with open-angle glaucoma to surgery with a miniature glaucoma shunt or standard trabeculectomy, both with mitomycin-C.

Latanoprostene bunod is a probable new drug for the treatment of glaucoma that seems to be well tolerated and potent in lowering IOP.

A new fixed-combination of brinzolamide-brimonidine is a safe and effective option for lowering IOP in patients who are not candidates for a beta-blocker.

There are several vital components surgeons need to take into consideration when treating children who have traumatic cataracts.

An investigational non-invasive imaging tool, phase-sensitive optical coherence tomography can be used to detect and measure movement of the trabecular meshwork in vivo.

In an analysis of almost 2,000 eyes treated with selective laser trabeculoplasty as primary therapy for glaucoma, mean IOP decreased 29% and the cumulative probability of success at 10 years was 90%.

Research shows circadian variations in IOP can be regulated by orexin-containing neurons located in the hypothalamus

In a comparison of two wavefront-guided excimer lasers, one platform provides better clinical results on some measures but cannot image certain eyes. The other system can image nearly all eyes, but has slightly less robust clinical results.

Visual loss and progressive thinning of the retinal nerve fiber layer (RNFL) occur over time in patients with multiple sclerosis (MS), according to results from a longitudinal study.

What can we ophthalmologists in the wealthiest country in the Western Hemisphere learn from the success stories of ophthalmic institutions in other countries with different cultures, histories, and degrees of wealth? A great deal, notes Peter J. McDonnell, MD.

Even though the end result may not be the most ideal for you, there are still people out there who will sacrifice if the conclusion benefits the majority.

Patient selection plays just as much of a role in the success of endoscopic cyclophotocoagulation as do surgical pearls. Identifying the proper patient population is a key for greater success.

As society continues to become more technologically advanced and patient expectations grow alongside, there is no better time for physicians to rework the antiquated eyedrop-centered glaucoma treatment regime. SLT offers the treatment efficacy and convenience patients today need and stands to give the 1970s-based management of glaucoma a long-awaited shake-up in the 2010s.

Early problems associated with femtosecond laser-assisted refractive cataract surgery have been successfully downsized thanks to ongoing platform improvements and the introduction of new surgical instruments and techniques.

A new eye vitamin and mineral supplement was introduced by Bausch + Lomb at the 2013 American Society of Retina Specialists annual meeting.

The CDSCO has granted regulatory approval to STAAR Surgical’s implantable lens technology in India.

San Francisco-The Glaucoma Research Foundation (GRF) has received a $3 million bequest, the largest gift in its history.

Treatment of thyroid eye disease varies greatly among physicians.

Quantel Medical’s selective laser trabeculoplasty (SLT) glaucoma laser has been approved by the FDA.

Second Sight Medical Products Inc.’s retinal prosthesis system has been approved by the Centers for Medicare and Medicaid Services (CMS) for both inpatient and outpatient settings of care payments beginning Oct. 1.

Health Canada has cleared ThromboGenics NV’s treatment for symptomatic vitreomacular adhesion (VMA).

InSite Vision Inc.’s drug delivery system has received a patent from the U.S. Patent and Trademark Office.

In comparing conventional slit lamp photography with iPhone images, it was found the smartphone produces higher quality pictures and in a more economical way.

Proactive handling of pre-existing dry eye in laser vision correction patients will improve the accuracy of custom ablations and lower the risk of postoperative dry eye-related problems

Cataract surgery not only can result in a reduction of IOP, it also provides benefits for future management of glaucoma.

John of Garland, writing some 900 years ago, provided excellent advice to the young persons of his time-advice that we ophthalmologists today would be wise to heed.

Diagnosis of allergic conjunctivitis, which can have a significant quality-of-life burden, may be overlooked or missed without a proper evaluation.

Clinicians share their thoughts on the roles of a dual-acting antihistamine/mast cell stabilizer and topical ester corticosteroid in the management of seasonal allergic conjunctivitis.